Lynda Charters

Justin Schweitzer, OD, FAAO, reports that glaucoma therapy is quickly moving to more innovative and targeted ways to treat glaucoma and lower the patient treatment burden.

During the Glaucoma 360 annual meeting, Dake K. Heuer, MD, delivered the Shaffer-Hetherington-Hoskins Lecture Keynote address, titled “Risk Factors for Glaucoma Progression.”

Novel therapeutic approaches and drug-delivery technologies are improving control of pain and inflammation after cataract and other ocular surgeries.